GO:0042797 tRNA transcription by RNA polymerase III: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

• GO:0042797 describes the biological process in which RNA polymerase III (Pol III) transcribes tRNA genes into precursor tRNAs, a foundational step in protein synthesis.
• Pol III is recruited to tRNA genes by the general transcription factors TFIIIC and TFIIIB, which recognize intragenic promoter elements (A-box and B-box) and assemble the preinitiation complex [1,4,5].
• Transcription initiation involves large-scale structural rearrangements of the Pol III machinery, including TFIIIB-mediated DNA bending and Pol III subunit movements.
• The process is tightly regulated by posttranslational modifications of Pol III subunits, the MAF1 repressor, and the ubiquitin ligase Rsp5, linking tRNA synthesis to nutrient and stress signaling [3,4,6,8].
• Dysregulation of tRNA transcription by Pol III is implicated in cancer, neurodegeneration, and developmental disorders, making it a target for experimental modeling [1,6].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise interrogation of Pol III components and their roles in disease [1,3].

Description

tRNA transcription by RNA polymerase III (GO:0042797) is the biological process in which RNA polymerase III (Pol III) synthesizes precursor tRNA molecules from tRNA genes. This process is essential for supplying the cell with tRNAs that decode mRNA during translation, and it represents one of the most highly regulated transcriptional programs in eukaryotes [4,6]. The core machinery includes Pol III itself, the general transcription factors TFIIIC and TFIIIB, and accessory factors that modulate initiation and elongation [1,5]. Because tRNA synthesis is directly coupled to cell growth and proliferation, its dysregulation has been linked to cancer, neurodegeneration, and other pathologies [1,6]. Researchers study GO:0042797 to understand how cells coordinate protein synthesis with environmental cues and to identify therapeutic targets within the Pol III machinery [3,8].

tRNA transcription by RNA polymerase III At A Glance

GO ID GO:0042797
GO term tRNA transcription by RNA polymerase III
Ontology biological_process
Synonym None
Major function Synthesis of precursor tRNA molecules by RNA polymerase III
Key factors RNA polymerase III, TFIIIC, TFIIIB, MAF1, Rsp5
Regulation Posttranslational modifications, nutrient signaling, stress responses
Disease relevance Cancer, neurodegeneration, developmental disorders

What Is GO:0042797?

GO:0042797, tRNA transcription by RNA polymerase III, is defined as the synthesis of transfer RNA (tRNA) molecules by RNA polymerase III. This process begins with the recognition of tRNA genes by the general transcription factors TFIIIC and TFIIIB, followed by recruitment of Pol III to form a preinitiation complex [1,4]. The transcription cycle proceeds through initiation, elongation, and termination, producing precursor tRNAs that are subsequently processed into mature tRNAs [2,5]. This term encompasses the regulated activity of Pol III at tRNA gene loci and the associated assembly and rearrangement of transcription factors [5,6].

Why Is tRNA transcription by RNA polymerase III Important in Cell Biology?

tRNA transcription by RNA polymerase III is a central determinant of translational capacity and cell growth. Because tRNAs are required for protein synthesis, the regulation of Pol III activity directly impacts proliferation, stress responses, and metabolic homeostasis [2,4]. Dysregulation of this process is increasingly recognized in human diseases, including cancer and neurological disorders, where altered tRNA levels contribute to disease progression [1,6]. Understanding GO:0042797 therefore provides insights into fundamental gene expression control and offers potential targets for therapeutic intervention [3,8].
• Supplies tRNAs for translation, linking transcription directly to protein synthesis.
• Integrates nutrient and stress signals via MAF1 and posttranslational modifications [4,8].
• Dysregulation is observed in cancer, where elevated tRNA synthesis supports proliferation.
• Mutations in Pol III subunits are associated with neurodegenerative and developmental disorders.
• Provides a model for studying transcription factor assembly and chromatin organization [5,7].
• Targeted by the ubiquitin ligase Rsp5, connecting tRNA synthesis to protein quality control.
• Serves as a paradigm for understanding RNA polymerase III-specific initiation mechanisms.
• Offers opportunities for CRISPR-based functional genomics and drug discovery [1,3].

What Happens During tRNA transcription by RNA polymerase III?

Promoter recognition and preinitiation complex assembly
In simple terms: First, helper proteins find tRNA genes and mark them for transcription.
tRNA genes contain intragenic promoter elements known as A-box and B-box, which are recognized by the general transcription factor TFIIIC [1,4]. TFIIIC binds these elements and recruits TFIIIB, a factor composed of TBP, Brf1, and Bdp1, to a position upstream of the transcription start site [4,5]. This assembly forms the preinitiation complex that is required for Pol III recruitment.
RNA polymerase III recruitment and initiation
In simple terms: The main enzyme, RNA polymerase III, is then brought in to start copying the gene.
TFIIIB recruits RNA polymerase III through interactions with its subunits, leading to the formation of an open promoter complex. Structural rearrangements within Pol III and TFIIIB facilitate DNA melting and positioning of the template strand in the active site. Initiation is accompanied by large-scale conformational changes in the Pol III machinery, as revealed by structural studies.
Elongation and termination
In simple terms: The enzyme moves along the gene, building the tRNA molecule, and then stops at a signal.
During elongation, Pol III synthesizes the tRNA transcript processively until it encounters a termination signal, typically a run of thymidine residues on the non-template strand. Termination involves release of the nascent tRNA and dissociation of the polymerase from the DNA. The resulting precursor tRNA undergoes processing to become a mature tRNA.
Regulation by posttranslational modifications and MAF1
In simple terms: The process can be sped up or slowed down by chemical tags on the enzyme and by a repressor protein.
Pol III activity is modulated by phosphorylation and other posttranslational modifications of its subunits, which can affect assembly and catalytic activity. The MAF1 protein acts as a global repressor of Pol III transcription, integrating signals from mTOR and other pathways. Additionally, the ubiquitin ligase Rsp5 regulates Pol III machinery and tRNA processing, linking tRNA synthesis to protein homeostasis.
Spatial organization and nuclear positioning
In simple terms: tRNA genes are not randomly placed; they are organized in the nucleus for efficient transcription.
tRNA genes are often clustered and associated with specific nuclear structures, such as the nucleolus and nuclear pore complexes, which can influence their transcription. Spatial organization of Pol III machinery and tRNA genes contributes to the efficiency and regulation of tRNA synthesis. This organization also facilitates the coupling of transcription with tRNA processing and export.

Key Genes Involved in GO:0042797 tRNA transcription by RNA polymerase III

The following genes and proteins are core components or regulators of tRNA transcription by RNA polymerase III (GO:0042797).
GeneMajor RoleResearch Relevance
POLR3A Catalytic subunit of RNA polymerase III Mutations linked to neurodegenerative disorders; target for knockout studies
POLR3B Second largest subunit of RNA polymerase III Essential for Pol III assembly and catalysis; studied in disease models
POLR3C Subunit of RNA polymerase III Involved in complex stability; potential CRISPR target
POLR3D Subunit of RNA polymerase III Required for tRNA transcription; used in functional assays
POLR3E Subunit of RNA polymerase III Contributes to initiation and elongation; studied via mutagenesis
POLR3F Subunit of RNA polymerase III Part of the Pol III core; relevant for structural studies
POLR3G Subunit of RNA polymerase III Associated with Pol III regulation; target for overexpression
POLR3H Subunit of RNA polymerase III Involved in transcription initiation; knockout models available
POLR3K Subunit of RNA polymerase III Small subunit with regulatory roles; studied in yeast and human cells
GTF3A TFIIIA, involved in 5S rRNA transcription but related to Pol III Model for Pol III factor specificity
GTF3C1 TFIIIC subunit, recognizes B-box promoter Key for tRNA gene recruitment; knockout affects tRNA synthesis
GTF3C2 TFIIIC subunit, binds A-box Essential for preinitiation complex assembly
BRF1 TFIIIB subunit, recruits Pol III Regulated by phosphorylation; target for point mutations [4,8]
BDP1 TFIIIB subunit, assists in DNA melting Required for initiation; studied via knock-in
TBP TATA-binding protein in TFIIIB Shared with other polymerases; conditional knockout models
MAF1 Repressor of Pol III transcription Integrates nutrient signaling; overexpression reduces tRNA synthesis
RSP5 Ubiquitin ligase regulating Pol III and tRNA processing Links tRNA synthesis to protein quality control

How Is tRNA transcription by RNA polymerase III Regulated?

tRNA transcription by RNA polymerase III is regulated at multiple levels. The MAF1 protein acts as a global repressor, and its activity is controlled by phosphorylation downstream of mTOR and other nutrient-sensing pathways. Posttranslational modifications of Pol III subunits, including phosphorylation and ubiquitination, modulate the assembly and activity of the transcription machinery. The ubiquitin ligase Rsp5 regulates both Pol III transcription machinery and tRNA processing, connecting tRNA synthesis to cellular stress and protein homeostasis. Additionally, spatial organization and chromatin context influence tRNA gene expression.

tRNA transcription by RNA polymerase III and Human Disease

GeneDisease / BiologyPotential Experimental Model
POLR3AHypomyelinating leukodystrophyKnock-in of patient mutations in cell lines
POLR3BNeurodegenerationKnockout and point mutation models
MAF1Cancer (tumor suppressor context)Overexpression and knockout in cancer cell lines
RSP5Protein homeostasis disordersKnockout in yeast and human cells
BRF1Developmental disordersPoint mutation knock-in [4,8]
Cancer
Elevated tRNA transcription by Pol III is frequently observed in cancer cells to support increased protein synthesis and proliferation. Dysregulation of Pol III machinery and its regulators, such as MAF1, can contribute to oncogenic transformation. Targeting Pol III transcription is being explored as a therapeutic strategy in multiple cancers.
Neurodegeneration
Mutations in Pol III subunits, particularly POLR3A and POLR3B, are associated with neurodegenerative disorders such as hypomyelinating leukodystrophies. Impaired tRNA synthesis can lead to translational stress and neuronal dysfunction. Model systems using patient-derived mutations help dissect these mechanisms.
Developmental disorders
Altered Pol III activity during development can affect growth and differentiation due to its role in tRNA supply. Mutations in general transcription factors like TFIIIC subunits have been linked to developmental abnormalities. Studying these mutations in model organisms provides insight into tissue-specific requirements.

From tRNA transcription by RNA polymerase III-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of POLR3A affect tRNA synthesis?CRISPR knockout in HEK293 or HeLa cells
How do disease-associated point mutations in POLR3B alter Pol III activity?Point mutation knock-in using CRISPR
Can tagged Pol III subunits be used to study complex assembly?Knock-in of epitope tags (e.g., FLAG, HA)
Does MAF1 overexpression repress tRNA transcription?Overexpression cell lines
What is the role of Rsp5 in tRNA processing?Knockout and rescue experiments
How does spatial organization affect tRNA gene transcription?Imaging with tagged Pol III subunits

How to Study the tRNA transcription by RNA polymerase III Process

MethodWhat It MeasuresTypical Application
RNA-seq/tRNA-seqtRNA transcript levelsAssessing Pol III activity after knockout
ChIP-seqOccupancy of Pol III and factors at tRNA genesStudying preinitiation complex assembly
Cryo-EM3D structure of Pol III complexesUnderstanding initiation and elongation mechanisms
Mass spectrometryPosttranslational modifications and interactorsMapping regulatory modifications
CRISPR knockoutLoss-of-function phenotypesDetermining essentiality of Pol III subunits
CRISPR knock-inTagged or mutant protein expressionStudying localization and function
OverexpressionGain-of-function effectsTesting MAF1 repression
ImagingSubcellular localization of Pol IIISpatial organization studies
RNA-seq and tRNA-seq
RNA sequencing, including specialized tRNA-seq protocols, measures the abundance of precursor and mature tRNAs to assess Pol III activity. This method can detect changes in tRNA gene expression upon genetic perturbations.
Chromatin immunoprecipitation (ChIP)
ChIP with antibodies against Pol III subunits or TFIIIC/TFIIIB components determines their occupancy at tRNA genes. It is used to study preinitiation complex assembly and dynamics.
Structural biology (cryo-EM and crystallography)
Cryo-electron microscopy and X-ray crystallography reveal the architecture and conformational changes of the Pol III machinery during initiation and elongation. These techniques provide mechanistic insights into transcription.
Proteomics and posttranslational modification analysis
Mass spectrometry-based proteomics identifies modifications on Pol III subunits and interacting proteins. It helps map regulatory networks controlling tRNA synthesis.

How CRISPR Can Be Used to Study GO:0042797 tRNA transcription by RNA polymerase III

Knockout

CRISPR knockout of Pol III subunits or regulators (e.g., POLR3A, MAF1) enables loss-of-function studies to determine their requirement for tRNA transcription and cell viability. Knockout cell lines are valuable for dissecting subunit-specific roles.

Point Mutation

Introducing disease-associated point mutations (e.g., in POLR3B) via CRISPR base editing or homology-directed repair allows precise modeling of altered Pol III activity. These models help link specific mutations to molecular phenotypes.

Knock-in

Knock-in of epitope tags (e.g., FLAG, HA) into endogenous Pol III subunit genes facilitates purification and imaging of the transcription machinery. This approach preserves native regulation and stoichiometry.

Overexpression

CRISPR activation or cDNA overexpression of Pol III subunits and regulators (e.g., MAF1) can test gain-of-function effects on tRNA synthesis. Overexpression models are useful for studying regulatory mechanisms.

How EDITGENE Supports tRNA transcription by RNA polymerase III Research

Researchers studying tRNA transcription by RNA polymerase III-related genes often need to determine whether a candidate gene is causally involved in tRNA synthesis, how specific mutations affect Pol III function, and whether altering gene dosage changes cellular phenotypes. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for tRNA transcription by RNA polymerase III research.

Related Products

Product name Cat.No. Species Gene ID
GTF3C6 Knockout HEK293 Cell Line EDJ-KQ7385 Human 112495 Details Get a Quote
GTF3C6 Knockout A-549 Cell Line EDJ-KQ32526 Human 112495 Details Get a Quote
GTF3C6 Knockout HCT 116 Cell Line EDJ-KQ32527 Human 112495 Details Get a Quote
GTF3C6 Knockout HeLa Cell Line EDJ-KQ32528 Human 112495 Details Get a Quote
POLR2F Knockout HEK293 Cell Line EDJ-KQ50523 Human 5435 Details Get a Quote
POLR2F Knockout HeLa Cell Line EDJ-KQ54170 Human 5435 Details Get a Quote
POLR2F Knockout A-549 Cell Line EDJ-KQ62667 Human 5435 Details Get a Quote
POLR2F Knockout HCT 116 Cell Line EDJ-KQ71134 Human 5435 Details Get a Quote

Frequently Asked Questions About tRNA transcription by RNA polymerase III

It is the process (GO:0042797) in which RNA polymerase III synthesizes precursor tRNA molecules from tRNA genes, using transcription factors TFIIIC and TFIIIB [2,4].
Key genes include POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K, GTF3C1, GTF3C2, BRF1, BDP1, TBP, MAF1, and RSP5 [1,3,4].
It is regulated by posttranslational modifications of Pol III subunits, the repressor MAF1, and the ubiquitin ligase Rsp5, integrating nutrient and stress signals [3,4,8].
Mutations in Pol III subunits are linked to hypomyelinating leukodystrophies and neurodegeneration, while elevated activity is observed in cancer [1,6].
TFIIIC recognizes intragenic A-box and B-box promoter elements and recruits TFIIIB to initiate preinitiation complex assembly.
MAF1 acts as a global repressor of Pol III transcription, and its activity is controlled by phosphorylation downstream of mTOR signaling.
Common methods include RNA-seq/tRNA-seq, ChIP-seq, cryo-EM, mass spectrometry, and CRISPR-based perturbations [2,5,8].
Yes, CRISPR knockout, point mutation knock-in, and overexpression models allow precise dissection of Pol III gene function in disease contexts.
tRNA genes and Pol III machinery are organized in specific nuclear compartments, such as the nucleolus and nuclear pore complexes, to optimize transcription.
Cancer cells often upregulate tRNA synthesis to support increased protein production and proliferation, making Pol III a potential therapeutic target.

Conclusion

tRNA transcription by RNA polymerase III (GO:0042797) is a fundamental biological process that supplies the cell with tRNAs for protein synthesis. Its intricate regulation by transcription factors, posttranslational modifications, and signaling pathways ensures that tRNA production matches cellular demand [2,4,8]. Dysregulation of this process contributes to cancer, neurodegeneration, and developmental disorders, highlighting its clinical relevance [1,6]. Advances in CRISPR-based modeling and structural biology continue to illuminate the mechanisms of Pol III transcription, offering new opportunities for therapeutic intervention [3,5].

References

  1. 1. Schwartz AM et al.. 2024. [Regulation of Transcription by RNA Polymerase III Promotors in the Norm and Pathology].. Mol Biol (Mosk) 58(2):220-233 PMID: 39355880
  2. 2. Turowski TW et al.. 2016. Transcription by RNA polymerase III: insights into mechanism and regulation.. Biochem Soc Trans 44(5):1367-1375 PMID: 27911719
  3. 3. Łopusińska A et al.. 2025. RNA polymerase III transcription machinery and tRNA processing are regulated by the ubiquitin ligase Rsp5.. Biochim Biophys Acta Mol Cell Res 1872(6):119993 PMID: 40398754
  4. 4. Graczyk D et al.. 2018. Regulation of tRNA synthesis by the general transcription factors of RNA polymerase III - TFIIIB and TFIIIC, and by the MAF1 protein.. Biochim Biophys Acta Gene Regul Mech 1861(4):320-329 PMID: 29378333
  5. 5. Ramsay EP et al.. 2018. Structural rearrangements of the RNA polymerase III machinery during tRNA transcription initiation.. Biochim Biophys Acta Gene Regul Mech 1861(4):285-294 PMID: 29155071
  6. 6. Leśniewska E et al.. 2017. Novel layers of RNA polymerase III control affecting tRNA gene transcription in eukaryotes.. Open Biol 7(2) PMID: 28228471
  7. 7. Haeusler RA et al.. 2006. Spatial organization of transcription by RNA polymerase III.. Nucleic Acids Res 34(17):4826-36 PMID: 16971453
  8. 8. Chymkowitch P et al.. 2018. Regulation of tRNA synthesis by posttranslational modifications of RNA polymerase III subunits.. Biochim Biophys Acta Gene Regul Mech 1861(4):310-319 PMID: 29127063
Contact Us
*
*
*
How did you hear about us: